Status:
UNKNOWN
McNeill Dysphagia Therapy Program Combined With Transcranial Magnetic Stimulation
Lead Sponsor:
Ankara City Hospital Bilkent
Conditions:
Dysphagia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aimed to investigate the effectiveness of the McNeill Dysphagia Therapy (MDTP) programme combined with Transcranial Magnetic Stimulation (TMS) in individuals with post-stroke dysphagia.
Detailed Description
Stroke is a neurological disorder that causes focal or global cerebral dysfunction caused by vascular causes, can last for 24 hours or longer, or may result in death. Many complications occur after st...
Eligibility Criteria
Inclusion
- Dysphagia Diagnosis of ischaemic stroke Over 18 years old Cognitively competent and co-operative
Exclusion
- Epilepsy or seizure risk record Carry metallic objects in the head (such as arterial clips, plates, screws), eye or brain
Key Trial Info
Start Date :
December 29 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06184711
Start Date
December 29 2023
End Date
December 30 2025
Last Update
December 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara City Hospital
Ankara, Turkey (Türkiye), 06800